Su‐Geun Yang

2.7k total citations · 1 hit paper
75 papers, 2.1k citations indexed

About

Su‐Geun Yang is a scholar working on Biomedical Engineering, Pulmonary and Respiratory Medicine and Biomaterials. According to data from OpenAlex, Su‐Geun Yang has authored 75 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Biomedical Engineering, 19 papers in Pulmonary and Respiratory Medicine and 19 papers in Biomaterials. Recurrent topics in Su‐Geun Yang's work include Nanoparticle-Based Drug Delivery (15 papers), Nanoplatforms for cancer theranostics (14 papers) and Drug Solubulity and Delivery Systems (6 papers). Su‐Geun Yang is often cited by papers focused on Nanoparticle-Based Drug Delivery (15 papers), Nanoplatforms for cancer theranostics (14 papers) and Drug Solubulity and Delivery Systems (6 papers). Su‐Geun Yang collaborates with scholars based in South Korea, China and Thailand. Su‐Geun Yang's co-authors include Rengarajan Baskaran, Junghan Lee, Kun Na, Zheyu Shen, Jie Feng, Aiguo Wu, Chang‐Koo Shim, Enkhzaya Davaa, Xuehua Ma and Ratchapol Jenjob and has published in prestigious journals such as Angewandte Chemie International Edition, Biomaterials and Scientific Reports.

In The Last Decade

Su‐Geun Yang

73 papers receiving 2.1k citations

Hit Papers

Clinical development of photodynamic agents and therapeut... 2018 2026 2020 2023 2018 100 200 300 400

Peers

Su‐Geun Yang
Jyothi U. Menon United States
Carlos H. Villa United States
Yumei Xie China
Hanze Hu United States
In‐Kyu Park South Korea
Yuan Ding China
Jyothi U. Menon United States
Su‐Geun Yang
Citations per year, relative to Su‐Geun Yang Su‐Geun Yang (= 1×) peers Jyothi U. Menon

Countries citing papers authored by Su‐Geun Yang

Since Specialization
Citations

This map shows the geographic impact of Su‐Geun Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su‐Geun Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su‐Geun Yang more than expected).

Fields of papers citing papers by Su‐Geun Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su‐Geun Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su‐Geun Yang. The network helps show where Su‐Geun Yang may publish in the future.

Co-authorship network of co-authors of Su‐Geun Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Su‐Geun Yang. A scholar is included among the top collaborators of Su‐Geun Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su‐Geun Yang. Su‐Geun Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yoo, Hye Jin & Su‐Geun Yang. (2024). Enhanced oral bioavailability of megestrol acetate via polymer-hybridized solid lipid nanoparticles using ultrasonic nebulization method. Journal of Pharmaceutical Investigation. 55(1). 105–112. 2 indexed citations
3.
Tangnorawich, Benchamaporn, et al.. (2024). Synthesis of Silver Nanoparticles and Gold Nanoparticles Used as Biosensors for the Detection of Human Serum Albumin-Diagnosed Kidney Disease. Pharmaceuticals. 17(11). 1421–1421. 4 indexed citations
4.
Yang, Jing, Jie Feng, Su‐Geun Yang, Yikai Xu, & Zheyu Shen. (2023). Exceedingly Small Magnetic Iron Oxide Nanoparticles for T1‐Weighted Magnetic Resonance Imaging and Imaging‐Guided Therapy of Tumors. Small. 19(49). e2302856–e2302856. 43 indexed citations
5.
Huang, Lin, Jie Feng, Jiaoyang Zhu, et al.. (2023). A Strategy of Fenton Reaction Cycloacceleration for High‐Performance Ferroptosis Therapy Initiated by Tumor Microenvironment Remodeling. Advanced Healthcare Materials. 12(18). 49 indexed citations
6.
Lu, Xuanyi, Yudie Lu, Meng Shi, et al.. (2023). Kilogram‐Scale Synthesis of Extremely Small Gadolinium Oxide Nanoparticles as a T1‐Weighted Contrast Agent for Magnetic Resonance Imaging. Small. 20(14). e2308547–e2308547. 9 indexed citations
7.
Guo, Shuai, Wei Xiong, Jiaoyang Zhu, et al.. (2023). A STING pathway-activatable contrast agent for MRI-guided tumor immunoferroptosis synergistic therapy. Biomaterials. 302. 122300–122300. 52 indexed citations
8.
Zhan, Jiezhao, Jianping Liu, Jing Yang, et al.. (2023). Ultrasmall Self-Cascade AuNP@FeS Nanozyme for H2S-Amplified Ferroptosis Therapy. ACS Applied Materials & Interfaces. 15(39). 46213–46225. 20 indexed citations
10.
Lu, Yudie, Jie Feng, Lin Huang, et al.. (2022). Facile Synthesis of Weakly Ferromagnetic Organogadolinium Macrochelates‐Based T1‐Weighted Magnetic Resonance Imaging Contrast Agents. Advanced Science. 10(1). e2205109–e2205109. 41 indexed citations
11.
Guo, Shuai, Jie Feng, Su‐Geun Yang, et al.. (2022). Improved cancer immunotherapy strategies by nanomedicine. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. 15(3). 21 indexed citations
12.
Nguyen, Hong Phuong, Seung‐Heon Shin, Quang De Tran, et al.. (2022). Protective effect of TPP-Niacin on microgravity-induced oxidative stress and mitochondrial dysfunction of retinal epithelial cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1870(1). 119384–119384. 9 indexed citations
13.
Jang, Sung Ill, Seok Jeong, Don Haeng Lee, et al.. (2019). Safety Evaluation of Paclitaxel-Eluting Biliary Metal Stent with Sodium Caprate in Porcine Biliary Tract. Gut and Liver. 13(4). 471–478. 10 indexed citations
14.
Kim, Minkyoung, et al.. (2018). Tumor-suppressing miR-141 gene complex-loaded tissue-adhesive glue for the locoregional treatment of hepatocellular carcinoma. Theranostics. 8(14). 3891–3901. 18 indexed citations
15.
Jenjob, Ratchapol, Kun Na, Jung Yeon Ghee, et al.. (2016). Enhanced conjugation stability and blood circulation time of macromolecular gadolinium-DTPA contrast agent. Materials Science and Engineering C. 61. 659–664. 21 indexed citations
16.
Song, Chung Kil, et al.. (2015). Nanomemulsion of megestrol acetate for improved oral bioavailability and reduced food effect. Archives of Pharmacal Research. 38(10). 1850–1856. 12 indexed citations
17.
Shen, Zheyu, Hao Wu, Su‐Geun Yang, et al.. (2015). A novel Trojan-horse targeting strategy to reduce the non-specific uptake of nanocarriers by non-cancerous cells. Biomaterials. 70. 1–11. 53 indexed citations
18.
Kim, Mina, et al.. (2012). Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: Analysis of isolated hepatic stellate cells. International Journal of Molecular Medicine. 30(3). 473–479. 69 indexed citations
19.
Balakrishnan, Prabagar, Chung Kil Song, Hyun‐Jong Cho, et al.. (2012). Inclusion complex effect on the bioavailability of clotrimazole from poloxamer-based solid suppository. Archives of Pharmacal Research. 35(7). 1169–1175. 3 indexed citations
20.
Yang, Su‐Geun, et al.. (2012). Gemcitabine-releasing polymeric films for covered self-expandable metallic stent in treatment of gastrointestinal cancer. International Journal of Pharmaceutics. 427(2). 276–283. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026